332 related articles for article (PubMed ID: 17241436)
1. Pilocarpine treatment in a mixed cohort of xerostomic patients.
Aframian DJ; Helcer M; Livni D; Robinson SD; Markitziu A; Nadler C
Oral Dis; 2007 Jan; 13(1):88-92. PubMed ID: 17241436
[TBL] [Abstract][Full Text] [Related]
2. Pilocarpine for the treatment of salivary glands' impairment caused by radioiodine therapy for thyroid cancer.
Aframian DJ; Helcer M; Livni D; Markitziu A
Oral Dis; 2006 May; 12(3):297-300. PubMed ID: 16700739
[TBL] [Abstract][Full Text] [Related]
3. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome.
Jorkjend L; Bergenholtz A; Johansson AK; Johansson A
Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333
[TBL] [Abstract][Full Text] [Related]
4. Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.
Nakamura N; Sasano N; Yamashita H; Igaki H; Shiraishi K; Terahara A; Asakage T; Nakao K; Ebihara Y; Ohtomo K; Nakagawa K
Auris Nasus Larynx; 2009 Jun; 36(3):310-3. PubMed ID: 18635328
[TBL] [Abstract][Full Text] [Related]
5. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
[TBL] [Abstract][Full Text] [Related]
7. A new medication for treatment of dry mouth in Sjögren's syndrome.
al-Hashimi I; Taylor SE
Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944
[TBL] [Abstract][Full Text] [Related]
8. The influence of pilocarpine and biperiden on pH value and calcium, phosphate, and bicarbonate concentrations in saliva during and after radiotherapy for head and neck cancer.
Rode M; smid L; Budihna M; Gassperssic D; Rode M; Soba E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Nov; 92(5):509-14. PubMed ID: 11709686
[TBL] [Abstract][Full Text] [Related]
9. Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study.
Chambers MS; Keene HJ; Toth BB; Lemon JC; Gallagher SC; Martin CG; Martin JW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Feb; 99(2):180-4. PubMed ID: 15660089
[TBL] [Abstract][Full Text] [Related]
10. Artificial saliva products and drugs to treat xerostomia.
Wynn RL; Meiller TF
Gen Dent; 2000; 48(6):630-6. PubMed ID: 12004654
[No Abstract] [Full Text] [Related]
11. Oral pilocarpine: new preparation. Xerostomia after radiation therapy: moderately effective but costly.
Prescrire Int; 2002 Aug; 11(60):99-101. PubMed ID: 12199276
[TBL] [Abstract][Full Text] [Related]
12. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
[TBL] [Abstract][Full Text] [Related]
13. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC
N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972
[TBL] [Abstract][Full Text] [Related]
14. Pilocarpine toxicity and the treatment of xerostomia.
Hendrickson RG; Morocco AP; Greenberg MI
J Emerg Med; 2004 May; 26(4):429-32. PubMed ID: 15093850
[TBL] [Abstract][Full Text] [Related]
15. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia.
Jha N; Seikaly H; Harris J; Williams D; Sultanem K; Hier M; Ghosh S; Black M; Butler J; Sutherland D; Kerr P; Barnaby P
Head Neck; 2009 Feb; 31(2):234-43. PubMed ID: 19107948
[TBL] [Abstract][Full Text] [Related]
16. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
[TBL] [Abstract][Full Text] [Related]
17. A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia.
Jacobs CD; van der Pas M
Oncology (Williston Park); 1996 Mar; 10(3 Suppl):16-20. PubMed ID: 8723429
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial.
Chitapanarux I; Kamnerdsupaphon P; Tharavichitkul E; Sumitsawan Y; Sittitrai P; Pattarasakulchai T; Lorvidhaya V; Sukthomya V; Pukanhaphan N; Traisatit P
J Med Assoc Thai; 2008 Sep; 91(9):1410-5. PubMed ID: 18843872
[TBL] [Abstract][Full Text] [Related]
19. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
Khurshudian AV
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
[TBL] [Abstract][Full Text] [Related]
20. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study.
Nagler RM; Nagler A
Bone Marrow Transplant; 1999 May; 23(10):1007-11. PubMed ID: 10373066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
